全部文献期刊会议图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Nathaniel M. Braman , Maryam Etesami , Prateek Prasanna ...
来源:[J].Breast Cancer Research(IF 5.872), 2017, Vol.19 (1)
摘要:In this study, we evaluated the ability of radiomic textural analysis of intratumoral and peritumoral regions on pretreatment breast cancer dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to predict pathological complete response (pCR) to neoadjuvant chemotherapy (...
作者:Sinead Toomey , Alexander J. Eustace , Joanna Fay ...
来源:[J].Breast Cancer Research(IF 5.872), 2017, Vol.19 (1)
摘要:... Because ERBB family mutations can activate the PI3K/AKT pathway and likely have similar canonical signalling effects to PI3K pathway mutations, we investigated their combined impact on response to neoadjuvant HER2-targeted therapies.
作者:Satoko Okamoto , Takayuki Yamada , Yoshihide Kanemaki ...
来源:[J].Breast Cancer(IF 1.33), 2016, Vol.23 (5), pp.789-796
摘要:Abstract(#br) Background(#br)To clarify appropriate timing for magnetic resonance examination to predict pathological complete response to neoadjuvant chemotherapy for patients with human epidermal growth factor receptor 2 (HER2)-positive and triple-negative breast cancers in ter...
作者:J. Barrou , M. Bannier , M. Cohen ...
来源:[J].The Breast(IF 2.491), 2017, Vol.32, pp.37-43
摘要:... We assessed pathological complete response (pCR) as a surrogate endpoint for disease free survival.(#br)Methods(#br)Between 2010 and 2016, 103 patients undergoing mastectomy after NACT and NART were recruited. After CT and RT were administrated, a completion mastectomy with I...
作者:Briete Goorts , Thiemo J. A. van Nijnatten , Linda de Munck ...
来源:[J].Breast Cancer Research and Treatment(IF 4.469), 2017, Vol.163 (1), pp.83-91
摘要:Pathological complete response (pCR) is the ultimate response in breast cancer patients treated with neoadjuvant chemotherapy (NCT). It might be a surrogate outcome for disease-free survival (DFS) and overall survival (OS). We studied the effect of clinical tumor stage (cT-stage)...
作者:Fatih Karatas , Gokmen Umut Erdem , Suleyman Sahin ...
来源:[J].The Breast(IF 2.491), 2017, Vol.32, pp.237-244
摘要:Abstract(#br)Purpose(#br)The relation between higher body mass index (BMI) and pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) in breast cancer (BC) is a controversial issue according to the data of Western and Asian patients. The aim of this study is to e...
作者:Alex Farr , Myriam Stolz , Lukas Baumann ...
来源:[J].The Breast(IF 2.491), 2017, Vol.33, pp.153-158
摘要:... The aim of this study was to determine the obesity-related effect on pathological complete response (pCR) and survival in women receiving full uncapped doses of NAC.(#br)Methods(#br)We retrospectively analyzed the data of all consecutive women who underwent anthracycline-ta...
作者:Mariko Asaoka , Kazutaka Narui , Nobuyasu Suganuma ...
来源:[J].European Journal of Surgical Oncology(IF 2.614), 2019, Vol.45 (12), pp.2289-2294
摘要:Abstract(#br)Introduction(#br)Despite the excellent prognosis associated with pathological complete response (pCR) to neoadjuvant chemotherapy (NAC), some patients still develop recurrence. Here, we investigated the outcomes of breast cancer patients with pCR, as well as the cl...
作者:Sieske Hoendervangers , Alice M. Couwenberg , Martijn P.W. Intven ...
来源:[J].European Journal of Surgical Oncology(IF 2.614), 2018, Vol.44 (7), pp.1013-1017
摘要:... This may lower their chances for complete tumor response and, as such, organ-sparing approaches. The purpose of this study was to compare the pathological complete response (pCR) rates between neoadjuvant CRT and SCRT-delay in patients with LARC in a nationwide database f...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×